Clinical Trial Update: Tideglusib for the Treatment of Amyotrophic Lateral Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Tideglusib in amyotrophic lateral sclerosis; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Tideglusib (tideglusib)

Snippet

Sponsor: University of Zurich | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: NOT_YET_RECRUITING